Previous studies show that the majority NMIBC patients experience side effects to BCG and
therefore terminate the instillations before completing all planned instillations. This will
increase their risk of recurrence and potential cystectomy. The purpose of this study is to
investigate if NMIBC patients who experience severe side effects to BCG instillations will
experience fewer or less severe side effects if reducing dwell-time of BCG instillations.
The study will include patients from Denmark, Iceland, Norway and Sweden.
Phase:
Phase 4
Details
Lead Sponsor:
Jørgen Bjerggaard Jensen
Collaborators:
Aalborg University Hospital Aarhus University Hospital Herlev Hospital Landspitali University Hospital Odense University Hospital Region Örebro County Regional Hospital West Jutland Rigshospitalet, Denmark Sahlgrenska University Hospital, Sweden The Hospital of Vestfold Zealand University Hospital